Immunomedics is a pharmaceutical company focusing on the development of monoclonal antibodies for the treatment of disease.
Immunomedics was founded in July 1982 by David M. Goldenberg, who has served on the board of directors since then. Cynthia Sullivan is the current CEO. In 2016, they had 131 employees.
2016-06-21 | Downgrade | Wells Fargo | Outperform to Market Perform | |
2016-06-21 | Downgrade | Wells Fargo & Co. | Outperform to Market Perform | |
2016-06-06 | Reiterated Rating | Jefferies Group | Buy | $5.00 |
2016-05-24 | Reiterated Rating | Wells Fargo | Buy | |
2016-05-06 | Upgrade | Jefferies Group | Hold to Buy | $1.50 to $5.00 |
2016-03-15 | Lower Price Target | Jefferies Group | Hold | $2.00 to $1.50 |
2016-02-05 | Upgrade | Wells Fargo | Market Perform to Buy | |
2015-12-04 | Downgrade | Wells Fargo | Outperform to Market Perform | |
2015-07-29 | Reiterated Rating | Oppenheimer | Outperform | |
2015-07-29 | Downgrade | Jefferies Group | Buy to Hold | $6.00 to $2.00 |
2015-07-29 | Reiterated Rating | Oppenheimer Holdings Inc. | Outperform | |
2015-01-16 | Initiated Coverage | Wells Fargo & Co. | Outperform to Fair Value | |
2015-01-16 | Initiated Coverage | Wells Fargo | Outperform to Fair Value | |
2015-01-07 | Initiated Coverage | Wells Fargo & Co. | Outperform to Outperform | $7.00 to $7.25 |
2015-01-07 | Initiated Coverage | Wells Fargo | Outperform to Outperform | $7.00 to $7.25 |
2014-09-30 | Reiterated Rating | Panmure Gordon | Buy | |
2014-09-23 | Initiated Coverage | Jefferies Group | Buy | $6.00 |
2014-08-27 | Downgrade | R. F. Lafferty | Buy to Neutral | $4.00 |
2014-01-08 | Initiated | Chardan Capital Markets | Buy | $9 |
2014-01-08 | Initiated Coverage | Chardan Capital | Buy | $9.00 |
2013-10-02 | Boost Price Target | Oppenheimer | Outperform | $6.00 to $8.00 |
2013-09-10 | Initiated | R. F. Lafferty | Buy | $8 |
2013-06-03 | Initiated | WallachBeth | Buy | $6 |
2011-08-31 | Initiated | Summer Street Research | Buy | $8 |
2011-07-28 | Initiated | Summer Street Research | Buy | $8 |
2011-02-23 | Initiated | Wedbush | Outperform | $6 |
2007-07-03 | Initiated | Brean Murray | Buy | $8 |
2007-02-20 | Initiated | Lazard Capital | Buy | $6 |
2016-06-21 | Downgrade | Wells Fargo | Outperform to Market Perform | |
2016-06-21 | Downgrade | Wells Fargo & Co. | Outperform to Market Perform | |
2016-06-06 | Reiterated Rating | Jefferies Group | Buy | $5.00 |
2016-05-24 | Reiterated Rating | Wells Fargo | Buy | |
2016-05-06 | Upgrade | Jefferies Group | Hold to Buy | $1.50 to $5.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In IMMU 24 funds of 2213 total. Show all
Fund name | Ticker shares |
---|---|
BlackRock Fund Advisors | 4.60M |
EverPoint Asset Management, LLC | 3.33M |
BlackRock Institutional Trust Company, N.A. | 2.86M |
J.P. Turner & Co Capital Mnagement, LLC | 0.40M |
Iguana Healthcare Management, LLC | 0.40M |
BlackRock Investment Management, LLC | 0.36M |
TEACHERS ADVISORS INC | 0.34M |
TIAA CREF INVESTMENT MANAGEMENT LLC | 0.27M |
COWEN GROUP, INC. | 0.15M |
Adamant Biomedical Investments AG | 0.15M |
Nair Vinay | 75434 |
BRINKER CAPITAL INC | 75052 |
BlackRock Group LTD | 60836 |
BLACKROCK ADVISORS LLC | 57576 |
BB&T SECURITIES, LLC | 49750 |
Name Relationship | Total Shares | Holding stocks |
---|---|---|
venBio Select Advisor LLC See Remarks | 20.29% (16939461) | IMMU / MRTX / |
Aghazadeh Behzad See Remarrks | 19.24% (16064461) | IMMU / |
GOLDENBERG DAVID M CSO, CMO and Chairman | 6.72% (5613252) | IMMU / |
GOLDENBERG CYNTHIA L President and CEO | 0.93% (778219) | IMMU / |
GORMAN GERARD G SVP, Fin. & Bus. Dev. & CFO | 0.14% (115671) | IMMU / |
MARKISON BRIAN A | 0.11% (90788) | ALR / IMMU / LNTH / PIP / |
PAETZOLD MARY E | 0.08% (67474) | IMMU / |
Stark Don C | 0.06% (51748) | IMMU / |
COLEMAN MORTON | 0.05% (39950) | IMMU / |
PFREUNDSCHUH PETER P. Chief Financial Officer | 0.04% (29706) | IMMU / SCMP / |
LoCastro Marcella | 0.02% (14950) | BIOC / IMMU / |
Sherman Richard L. | 0.01% (12130) | IMMU / TLOG / |
ZUERBLIS KENNETH J | 0.01% (9167) | IMMU / STML / |
Wolynic Edward T | 0.01% (6667) | IMMU / |